Published by Alexander Bueso on 17th April 2020
(Sharecast News) - Analysts at RBC Capital sounded a positive note on reports published overnight regarding the results of a phase III clinical trial at a Chicago hospital for Gilead Science's Remdesivir drug for treating Covid-19.
URL: http://www.digitallook.com/dl/news/story/30544550/...